U.S. Concrete Inc. (USCR) Jumps 13.14% on January 14

Equities Staff |

U.S. Concrete Inc. (USCR) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 13.14% to $47.71, representing a gain of $5.54 per share. Some 579,390 shares traded hands on 5,983 trades, compared with an average daily volume of 189,224 shares out of a total float of 14.65 million. The stock opened at $44.34 and traded with an intraday range of $47.82 to $44.34.

After today's gains, U.S. Concrete Inc. reached a market cap of $699.18 million. U.S. Concrete Inc. has had a trading range between $62.82 and $25.02 over the last year, and it had a 50-day SMA of $54.97 and a 200-day SMA of $46.68.

US Concrete Inc is a holding company. The Company through its subsidiaries is engaged in producing & providing ready-mixed concrete, aggregates and concrete-related products and services to the construction industry in the markets in the United States.

U.S. Concrete Inc. is based out of Euless, TX and has some 2,144 employees. Its CEO is William J. Sandbrook.

For a complete fundamental analysis analysis of U.S. Concrete Inc., check out Equities.com’s Stock Valuation Analysis report for USCR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.